MMedication Read More Launch prices for new drugs ‘significantly’ exceed inflation, analysis saysOctober 23, 2025 Amid intensifying angst over prescription drug prices, a new analysis found that the median net price for 154…
HHealthcare Read More Novo Nordisk board members step down after major shareholder disputeOctober 21, 2025 The logos of Danish drugmaker Novo Nordisk, maker of the blockbuster diabetes and weight-loss treatments Ozempic and Wegovy…
HHealth Read More New study offers hope for patients with treatment-resistant focal epilepsyOctober 21, 2025 About one-third of patients with focal epilepsy, a common form of the neurological disorder, are believed to respond…
MMental health Read More ‘Girl, Take Your Crazy Pills!’ Antidepressants Recast as a Hot Lifestyle AccessoryOctober 20, 2025 Corinne Byerley, a stay-at-home mom, recalled days when she felt lonely, overwhelmed and, at times, paralyzed with anxiety…
BBusiness Read More Singapore, ‘so dependent on external demand’, braces for tariff hitOctober 15, 2025 Businesses in Singapore — one of the most trade-exposed economies in the world — have been watching the…
GGenetics Read More Largest study of African American brain tissue reveals key Alzheimer gene activityOctober 8, 2025 The prevalence of Alzheimer disease (AD) is approximately two times higher in African Americans (AA) compared to White/European-ancestry…
HHealth Read More Innovative approaches target PAR2 receptor to alleviate gut painOctober 7, 2025 Abdominal pain is a hallmark of many digestive disorders, including inflammatory bowel disease and irritable bowel syndrome. In…
MMedication Read More What will TrumpRx mean for patients? Who saves — and how muchOctober 2, 2025 Could “TrumpRx” be the prescription for lower drug prices? President Donald Trump announced a landmark deal with Pfizer…
BBusiness Read More From pharmaceuticals to kitchen cabinets, Trump’s tariff program expandsOctober 2, 2025 US consumers have been spared largely from the inflationary effects of the Trump administration tariffs so far, but…
HHealthcare Read More Big Pharma’s retreat: Is NHS pricing behind investor pullbacks?October 1, 2025 ADVERTISEMENT Relations between Big Pharma and the UK government are under growing strain. Just last week, Eli Lilly…
HHealthcare Read More Lilly’s Kisunla (donanemab) receives marketing authorization by European Commission for the treatment of early symptomatic Alzheimer’s diseaseSeptember 27, 2025 Approved for earliest symptomatic stages of disease, demonstrating significant slowing of cognitive and functional decline Only therapy with…
MMedication Read More Natural Plant Compound Shows Promise for Treating Gum DiseaseSeptember 26, 2025 A natural compound called morin, found in fruits, teas, and nuts, is showing promise as a new tool…